Literature DB >> 17230441

TREM-1 promotes survival during septic shock in mice.

Sébastien Gibot1, Frederic Massin, Markella Marcou, Valerie Taylor, Ray Stidwill, Peter Wilson, Mervyn Singer, Geoff Bellingan.   

Abstract

Triggering receptor expressed on myeloid (TREM)-1 is integral to the inflammatory response occurring during septic shock, although its precise function has yet to be determined. Here we show that in vivo silencing of TREM-1 using siRNA duplexes in a fecal peritonitis mouse model resulted in a blunted inflammatory response and increased mortality. This was associated with impaired bacterial clearance related to marked inhibition of the neutrophil oxidative burst. By contrast, TREM-1-silenced mice were highly resistant to a lethal endotoxin challenge, while partial silencing of TREM-1 in the bacterial peritonitis model produced a significant survival benefit. These data highlight the crucial role of the TREM-1 pathway in mounting an adequate inflammatory and cytotoxic response to polymicrobial sepsis, and both the therapeutic promise and potential risks of its modulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17230441     DOI: 10.1002/eji.200636387

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  46 in total

1.  Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.

Authors:  Gimano D Amatngalim; Anastasia Nijnik; Pieter S Hiemstra; Robert E W Hancock
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

2.  TREM-1 is a positive regulator of TNF-α and IL-8 production in U937 foam cells.

Authors:  Yu-Shi Wang; Xiang-Jun Li; Wai-Ou Zhao
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

3.  Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.

Authors:  Marc Derive; Frédéric Massin; Sébastien Gibot
Journal:  Self Nonself       Date:  2010-07-02

4.  TREM-1 promotes survival during Klebsiella pneumoniae liver abscess in mice.

Authors:  Yi-Tsung Lin; Kai-Yu Tseng; Yi-Chen Yeh; Fu-Chen Yang; Chang-Phone Fung; Nien-Jung Chen
Journal:  Infect Immun       Date:  2014-01-06       Impact factor: 3.441

5.  TLT2 potentiates neutrophil antibacterial activity and chemotaxis in response to G protein-coupled receptor-mediated signaling.

Authors:  Matthew M Halpert; Kimberly A Thomas; R Glenn King; Louis B Justement
Journal:  J Immunol       Date:  2011-07-29       Impact factor: 5.422

Review 6.  Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis.

Authors:  Steven J Palazzo; Terri Simpson; Lynn M Schnapp
Journal:  Dimens Crit Care Nurs       Date:  2012 Jan-Feb

7.  TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine.

Authors:  Zhihong Yuan; Mansoor Syed; Dipti Panchal; Myungsoo Joo; Chetna Bedi; Sokbee Lim; Hayat Onyuksel; Israel Rubinstein; Marco Colonna; Ruxana T Sadikot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

8.  Etomidate Mitigates Lipopolysaccharide-Induced CD14 and TREM-1 Expression, NF-κB Activation, and Pro-inflammatory Cytokine Production in Rat Macrophages.

Authors:  Ming Liu; Yu Zhang; Jun-Yu Xiong; Yan Wang; Shen Lv
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 9.  TREM and TREM-like receptors in inflammation and disease.

Authors:  Jill W Ford; Daniel W McVicar
Journal:  Curr Opin Immunol       Date:  2009-02-21       Impact factor: 7.486

10.  Activation of the TREM-1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria.

Authors:  M Varanat; E M Haase; J G Kay; F A Scannapieco
Journal:  Mol Oral Microbiol       Date:  2016-09-06       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.